This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1994 Aug;38(2):93.

doi: 10.1111/j.1365-2125.1994.tb04329.x.

Why the Safety Assessment of Marketed Medicines (SAMM) guidelines are needed

P C Waller¹, S M Wood, A M Breckenridge, M D Rawlins

Affiliations

PMID: 7981018
PMCID: PMC1364851
DOI: 10.1111/j.1365-2125.1994.tb04329.x

Comment

Why the Safety Assessment of Marketed Medicines (SAMM) guidelines are needed

P C Waller et al. Br J Clin Pharmacol. 1994 Aug.

. 1994 Aug;38(2):93.

doi: 10.1111/j.1365-2125.1994.tb04329.x.

Authors

P C Waller¹, S M Wood, A M Breckenridge, M D Rawlins

Affiliation

¹ Medicines Control Agency, London.

PMID: 7981018
PMCID: PMC1364851
DOI: 10.1111/j.1365-2125.1994.tb04329.x

No abstract available

PubMed Disclaimer

Comment on

Guidelines for company-sponsored Safety Assessment of Marketed Medicines (SAMM) guidelines. Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association and Association of the British Pharmaceutical Industry (November 1993).
[No authors listed] [No authors listed] Br J Clin Pharmacol. 1994 Aug;38(2):95-7. doi: 10.1111/j.1365-2125.1994.tb04330.x. Br J Clin Pharmacol. 1994. PMID: 7981019 Free PMC article. No abstract available.

References

1. BMJ. 1992 Jun 6;304(6840):1470-2 - PubMed
1. Health Trends. 1993;25(3):83 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources